Predicting GPR40 Agonists with A Deep Learning‐Based Ensemble Model

Recent studies have identified G protein‐coupled receptor 40 (GPR40) as a promising target for treating type 2 diabetes mellitus, and GPR40 agonists have several superior effects over other hypoglycemic drugs, including cardiovascular protection and suppression of glucagon levels. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiamin, Jiang, Chen, Chen, Jing, Qin, Lu‐Ping, Cheng, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661831/
https://www.ncbi.nlm.nih.gov/pubmed/37404062
http://dx.doi.org/10.1002/open.202300051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661831/
https://www.ncbi.nlm.nih.gov/pubmed/37404062
http://dx.doi.org/10.1002/open.202300051

Ejemplares similares